Close Menu

NEW YORK (GenomeWeb) – Cypress, California-based DiaSorin Molecular said today that it has received CE marking for its Simplexa HSV 1/2 & VZV Universal Direct MDx assay designed for use on the firm's Liaison MDx instrument.

The assay uses cutaneous and mucocutaneous swab specimens for the direct detection and differentiation of DNA associated with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV).

Testing for VZV with HSV-1 and HSV-2 may enable clinicians to provide improved therapeutic decisions and advice, DiaSorin said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.